Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
10 mg/5 ml
5 ml ampoule
৳700.00 per pack

Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.

All price changes →
From ৳700.00 5 ml ampoule
Available as: 10 mg/5 ml · 5 ml ampoule

More from Cisatracurium Hameln

Other strengths and forms by ZAS Corporation

Indications & Uses

Cisatracurium Besylate is a neuromuscular blocking agent with an intermediate onset and an intermediate duration of action. It is used in inpatients and outpatients as an adjunct to general anesthesia. It helps with tracheal intubation, and it relaxes the skeletal muscles during surgery or during mechanical ventilation in the ICU.

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Adults: Initial Doses: You can choose one of two intubating doses of Cisatracurium, depending on how soon you need to intubate the trachea and how long the surgery is expected to last. The dose of the neuromuscular blocking agent is not the only thing that matters. Co-induction agents (for example fentanyl and midazolam) and the depth of anesthesia also influence intubation conditions. Doses of 0.15 (3 × ED95) and 0.20 (4 × ED95) mg/kg Cisatracurium, given as part of a propofol/nitrous oxide/oxygen induction-intubation technique, may generally produce GOOD or EXCELLENT intubation conditions in 2.0 and 1.5 minutes, respectively. You can expect similar conditions when these doses are given as part of a thiopental/nitrous oxide/oxygen induction-intubation technique. In two intubation studies that used thiopental or propofol with midazolam and fentanyl as co-induction agents, EXCELLENT conditions were reached most often with the 0.2 mg/kg dose of cisatracurium, compared with the 0.15 mg/kg dose. During propofol anesthesia, the clinically effective duration of action is 55 minutes (range: 44 to 74 minutes) for 0.15 mg/kg and 61 minutes (range: 41 to 81 minutes) for 0.20 mg/kg Cisatracurium. Lower doses may take longer to give satisfactory intubation conditions. Doses up to 8 × ED95 Cisatracurium have been given safely to healthy adult patients and to patients with serious cardiovascular disease. These larger doses last longer in clinically effective action.

Children: Initial Doses: The recommended dose of Cisatracurium for children 2 to 12 years of age is 0.10 to 0.15 mg/kg, given over 5 to 10 seconds during either halothane or opioid anesthesia. During stable opioid/nitrous oxide/oxygen anesthesia, 0.10 mg/kg Cisatracurium produces maximum neuromuscular block in an average of 2.8 minutes (range: 1.8 to 6.7 minutes), and the block stays clinically effective for 28 minutes (range: 21 to 38 minutes). With 0.15 mg/kg under the same stable anesthesia, maximum neuromuscular block comes in about 3.0 minutes (range: 1.5 to 8.0 minutes), and clinically effective block (time to 25% recovery) lasts 36 minutes (range: 29 to 46 minutes).

Infants: Initial Doses: For intubation of infants 1 month to 23 months old, the recommended dose of Cisatracurium is 0.15 mg/kg, given over 5 to 10 seconds during either halothane or opioid anesthesia. During stable opioid/nitrous oxide/oxygen anesthesia, 0.15 mg/kg produces maximum neuromuscular block in about 2.0 minutes (range: 1.3 to 3.4 minutes), and clinically effective block (time to 25% recovery) lasts about 43 minutes (range: 34 to 58 minutes).

Side Effects

Like all medicines, Cisatracurium Besylate Injection can cause side effects, although not everybody gets them. If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. Allergic reactions affect less than 1 in 10,000 people. The signs are sudden wheeziness, chest pain or chest tightness, swelling of your eyelids, face, lips, mouth or tongue, a lumpy skin rash anywhere on your body, and a collapse and shock. Common side effects affect less than 1 in 10 people, and they are a decrease in heart rate and a decrease in blood pressure. Uncommon side effects affect less than 1 in 100 people. These are a rash or redness of your skin, and wheezing or coughing. Very rare side effects affect less than 1 in 10,000 people, and they are weak or aching muscles.

Cautions & Contraindications

Warnings & Precautions

Cisatracurium Besylate has an intermediate onset of action, so it isn't recommended for rapid sequence endotracheal intubation. At the recommended doses it has no clinically significant effect on heart rate. This means it won't counteract the bradycardia caused by many anesthetic agents or by vagal stimulation. Neuromuscular blocking agents can have a profound effect in patients with neuromuscular diseases (for example myasthenia gravis and the myasthenic syndrome). The same applies to other conditions where a prolonged neuromuscular block is possible (for example carcinomatosis). In these patients, a peripheral nerve stimulator should be used to assess the level of neuromuscular block and to monitor dosage requirements, and the dose of Cisatracurium Besylate should not be more than 0.02 mg/kg. Patients with burns have been shown to develop resistance to nondepolarizing neuromuscular blocking agents, including atracurium. How much the response changes depends on the size of the burn and the time since the injury. Cisatracurium Besylate has not been studied in burn patients. Because its structure is similar to atracurium, though, the possibility of higher dosing requirements and a shorter duration of action must be considered if it is given to them. Patients with hemiparesis or paraparesis may also show resistance to nondepolarizing muscle relaxants in the affected limbs. To avoid inaccurate dosing, neuromuscular monitoring should be done on a non-paretic limb. Acid-base and/or serum electrolyte abnormalities may increase or oppose the action of neuromuscular blocking agents. No data are available to support the use of Cisatracurium Besylate by intramuscular injection.

Contraindications

Cisatracurium should not be given to anyone with known hypersensitivity to the product or any of its components. The 10 mL multiple-dose vials of Cisatracurium must not be used in premature infants, because the formulation contains benzyl alcohol.

Pregnancy & Breastfeeding

Cisatracurium Besylate is Pregnancy Category B. Nobody knows yet whether cisatracurium besylate passes into human breast milk. Many drugs do pass into milk, so a doctor should be careful when giving Cisatracurium Besylate to a woman who is breastfeeding.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Storage

Keep Cisatracurium Besylate out of the sight and reach of children. Don't use it after the expiry date printed on the label and the carton after "Exp". The expiry date means the last day of that month.

Store the ampoules in a refrigerator (2°C - 8°C) and do not freeze them. Leave them in the outer carton so they stay protected from light.

Drug Interactions

Open checker →

Common questions about Cisatracurium Hameln 10 mg/5 ml

What is Cisatracurium Hameln 10 mg/5 ml IV Infusion?

Cisatracurium Hameln 10 mg/5 ml IV Infusion is a medicine that contains Cisatracurium Besylate. It is made by ZAS Corporation.

What is Cisatracurium Hameln used for?

Cisatracurium Besylate is a neuromuscular blocking agent with an intermediate onset and an intermediate duration of action. It is used in inpatients and outpatients as an adjunct to general anesthesia.

What are the side effects of Cisatracurium Hameln?

Like all medicines, Cisatracurium Besylate Injection can cause side effects, although not everybody gets them. If you get any side effects, talk to your doctor, nurse or pharmacist.

Can I take Cisatracurium Hameln during pregnancy or while breastfeeding?

Cisatracurium Besylate is Pregnancy Category B. Nobody knows yet whether cisatracurium besylate passes into human breast milk. Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

How should I store Cisatracurium Hameln?

Keep Cisatracurium Besylate out of the sight and reach of children. Don't use it after the expiry date printed on the label and the carton after "Exp".

Can I take other medicines with Cisatracurium Hameln?

Some medicines can interact with Cisatracurium Besylate, for example: Vecuronium Bromide, Clindamycin, Colistin Sulphate, Atracurium Besylate, Propofol, Nitrous Oxide. Tell your doctor or pharmacist about every medicine you take.

Do I need a prescription for Cisatracurium Hameln?

Cisatracurium Hameln is a prescription (Rx) medicine. Take it as your doctor advises.

Last updated: 20 Aug 2026